Pathway to Stop Diabetes is a bold, innovative initiative designed to radically transform diabetes research. To accelerate the research needed to discover solutions and ultimately cure this deadly epidemic, the American Diabetes Association is launching a bold new initiative, Pathway to Stop Diabetes, to inspire a new generation of diabetes researchers. Pathway will provide crucial support to individuals focusing on innovative ideas and transformational approaches that will lead to ground‐breaking discoveries in diabetes prevention, treatment and cures.
Pathway will consider applications directed toward topics relevant to the prevention, treatment and cure of all diabetes types (type 1, type 2 and gestational), diabetes‐related disease states (obesity, pre‐diabetes, and other insulin resistant states) and diabetes complications. The program intends to attract individuals with a broad range of expertise in various science and technology disciplines, including medicine, biology, chemistry, computing and engineering, to the field of diabetes research.
Institutions may nominate a maximum of one investigator per grant cycle. The nomination can be in either of the Pathway award types:
Nominees must have the appropriate full‐time position to be eligible for the award at the sponsoring institution (postdoctoral fellow for Initiator, independent faculty appointment for Accelerator). Nominees are required to devote at least 75% of their total time and effort to research during the funding period.
Nominations for individuals proposing innovative and transformational basic, clinical, translational, epidemiological or health services research that is relevant to any type of diabetes, diabetes-related disease state or complication are welcomed. Nominations of candidates in diverse disciplines, from medicine, biology and chemistry to engineering, mathematics and physics, are encouraged.
Internal Selection Process
Admin/Reviewer Login here first
Back to the WINS main page